Global Nasal Drug Delivery Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2024

  • receipt Report ID : 157808
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 117
  • list Pharmaceuticals and Healthcare

Nasal Drug Delivery is a route of administration in which drugs are insufflated through the nose. It can be a form of either topical administration or systemic administration, as the drugs thus locally delivered can go on to have either purely local or systemic effects. Nasal sprays are locally acting drugs such as decongestants for cold and allergy treatment, whose systemic effects are usually minimal.

Scope of the Report:

This report studies the Nasal Drug Delivery market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Nasal Drug Delivery market by product type and applications/end industries.

The nasal cavity is covered by a thin mucosa which is well vascularised. Therefore, a drug molecule can be transferred quickly across the single epithelial cell layer directly to the systemic blood circulation without first-pass hepatic and intestinal metabolism. The effect is often reached within 5 min for smaller drug molecules. Nasal administration can therefore be used as an alternative to oral administration, by crushing or grinding tablets or capsules and snorting or sniffing the resulting powder, providing a rapid onset of effects.

The global Nasal Drug Delivery market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Nasal Drug Delivery.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Novartis

Pfizer

Sanofi-Aventis

Merck

AptarGroup

Johnson & Johnson Services

GlaxoSmithKline

Becton Dickson & Company

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Drops

Sprays

Powder

Gels and Ointments

Market Segment by Applications, can be divided into

Allergic And Non-allergic Rhinitis

Nose Congestion

Vaccination

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Nasal Drug Delivery Market Overview

1.1 Product Overview and Scope of Nasal Drug Delivery

1.2 Classification of Nasal Drug Delivery by Types

1.2.1 Global Nasal Drug Delivery Revenue Comparison by Types (2017-2023)

1.2.2 Global Nasal Drug Delivery Revenue Market Share by Types in 2017

1.2.3 Drops

1.2.4 Sprays

1.2.5 Powder

1.2.6 Gels and Ointments

1.3 Global Nasal Drug Delivery Market by Application

1.3.1 Global Nasal Drug Delivery Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Allergic And Non-allergic Rhinitis

1.3.3 Nose Congestion

1.3.4 Vaccination

1.4 Global Nasal Drug Delivery Market by Regions

1.4.1 Global Nasal Drug Delivery Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Nasal Drug Delivery Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Nasal Drug Delivery Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Nasal Drug Delivery Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Nasal Drug Delivery Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Nasal Drug Delivery Status and Prospect (2013-2023)

1.5 Global Market Size of Nasal Drug Delivery (2013-2023)

2 Manufacturers Profiles

2.1 Novartis

2.1.1 Business Overview

2.1.2 Nasal Drug Delivery Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Novartis Nasal Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

2.2 Pfizer

2.2.1 Business Overview

2.2.2 Nasal Drug Delivery Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Pfizer Nasal Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

2.3 Sanofi-Aventis

2.3.1 Business Overview

2.3.2 Nasal Drug Delivery Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Sanofi-Aventis Nasal Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

2.4 Merck

2.4.1 Business Overview

2.4.2 Nasal Drug Delivery Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Merck Nasal Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

2.5 AptarGroup

2.5.1 Business Overview

2.5.2 Nasal Drug Delivery Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 AptarGroup Nasal Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

2.6 Johnson & Johnson Services

2.6.1 Business Overview

2.6.2 Nasal Drug Delivery Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Johnson & Johnson Services Nasal Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

2.7 GlaxoSmithKline

2.7.1 Business Overview

2.7.2 Nasal Drug Delivery Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 GlaxoSmithKline Nasal Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

2.8 Becton Dickson & Company

2.8.1 Business Overview

2.8.2 Nasal Drug Delivery Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Becton Dickson & Company Nasal Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)

3 Global Nasal Drug Delivery Market Competition, by Players

3.1 Global Nasal Drug Delivery Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Nasal Drug Delivery Players Market Share

3.2.2 Top 10 Nasal Drug Delivery Players Market Share

3.3 Market Competition Trend

4 Global Nasal Drug Delivery Market Size by Regions

4.1 Global Nasal Drug Delivery Revenue and Market Share by Regions

4.2 North America Nasal Drug Delivery Revenue and Growth Rate (2013-2018)

4.3 Europe Nasal Drug Delivery Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Nasal Drug Delivery Revenue and Growth Rate (2013-2018)

4.5 South America Nasal Drug Delivery Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Nasal Drug Delivery Revenue and Growth Rate (2013-2018)

5 North America Nasal Drug Delivery Revenue by Countries

5.1 North America Nasal Drug Delivery Revenue by Countries (2013-2018)

5.2 USA Nasal Drug Delivery Revenue and Growth Rate (2013-2018)

5.3 Canada Nasal Drug Delivery Revenue and Growth Rate (2013-2018)

5.4 Mexico Nasal Drug Delivery Revenue and Growth Rate (2013-2018)

6 Europe Nasal Drug Delivery Revenue by Countries

6.1 Europe Nasal Drug Delivery Revenue by Countries (2013-2018)

6.2 Germany Nasal Drug Delivery Revenue and Growth Rate (2013-2018)

6.3 UK Nasal Drug Delivery Revenue and Growth Rate (2013-2018)

6.4 France Nasal Drug Delivery Revenue and Growth Rate (2013-2018)

6.5 Russia Nasal Drug Delivery Revenue and Growth Rate (2013-2018)

6.6 Italy Nasal Drug Delivery Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Nasal Drug Delivery Revenue by Countries

7.1 Asia-Pacific Nasal Drug Delivery Revenue by Countries (2013-2018)

7.2 China Nasal Drug Delivery Revenue and Growth Rate (2013-2018)

7.3 Japan Nasal Drug Delivery Revenue and Growth Rate (2013-2018)

7.4 Korea Nasal Drug Delivery Revenue and Growth Rate (2013-2018)

7.5 India Nasal Drug Delivery Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Nasal Drug Delivery Revenue and Growth Rate (2013-2018)

8 South America Nasal Drug Delivery Revenue by Countries

8.1 South America Nasal Drug Delivery Revenue by Countries (2013-2018)

8.2 Brazil Nasal Drug Delivery Revenue and Growth Rate (2013-2018)

8.3 Argentina Nasal Drug Delivery Revenue and Growth Rate (2013-2018)

8.4 Colombia Nasal Drug Delivery Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Nasal Drug Delivery by Countries

9.1 Middle East and Africa Nasal Drug Delivery Revenue by Countries (2013-2018)

9.2 Saudi Arabia Nasal Drug Delivery Revenue and Growth Rate (2013-2018)

9.3 UAE Nasal Drug Delivery Revenue and Growth Rate (2013-2018)

9.4 Egypt Nasal Drug Delivery Revenue and Growth Rate (2013-2018)

9.5 Nigeria Nasal Drug Delivery Revenue and Growth Rate (2013-2018)

9.6 South Africa Nasal Drug Delivery Revenue and Growth Rate (2013-2018)

10 Global Nasal Drug Delivery Market Segment by Type

10.1 Global Nasal Drug Delivery Revenue and Market Share by Type (2013-2018)

10.2 Global Nasal Drug Delivery Market Forecast by Type (2018-2023)

10.3 Drops Revenue Growth Rate (2013-2023)

10.4 Sprays Revenue Growth Rate (2013-2023)

10.5 Powder Revenue Growth Rate (2013-2023)

10.6 Gels and Ointments Revenue Growth Rate (2013-2023)

11 Global Nasal Drug Delivery Market Segment by Application

11.1 Global Nasal Drug Delivery Revenue Market Share by Application (2013-2018)

11.2 Nasal Drug Delivery Market Forecast by Application (2018-2023)

11.3 Allergic And Non-allergic Rhinitis Revenue Growth (2013-2018)

11.4 Nose Congestion Revenue Growth (2013-2018)

11.5 Vaccination Revenue Growth (2013-2018)

12 Global Nasal Drug Delivery Market Size Forecast (2018-2023)

12.1 Global Nasal Drug Delivery Market Size Forecast (2018-2023)

12.2 Global Nasal Drug Delivery Market Forecast by Regions (2018-2023)

12.3 North America Nasal Drug Delivery Revenue Market Forecast (2018-2023)

12.4 Europe Nasal Drug Delivery Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Nasal Drug Delivery Revenue Market Forecast (2018-2023)

12.6 South America Nasal Drug Delivery Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Nasal Drug Delivery Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Nasal Drug Delivery Picture

Table Product Specifications of Nasal Drug Delivery

Table Global Nasal Drug Delivery and Revenue (Million USD) Market Split by Product Ty

Please fill the form below, to recieve the report sample


+1